Abstract
Introduction: The risk of ipsilateral breast tumour recurrence (IBTR) following neoadjuvant chemotherapy and breast conserving surgery (BCS) for invasive breast cancer (IBC) is reported as 4 - 21.5%. Our aim was to perform an audit of local recurrence rates in patients undergoing neoadjuvant chemotherapy who were treated with BCS from 2000-2011. Mastectomy was performed in patients with a significant disease burden or at patient's request.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
